Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of TNF inhibitor interruption on endothelial function in rheumatoid arthritis
NL-OMON37380Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of infliximab in rheumatoid arthritis (RA) (2 arms), sponsored by Radboud University Medical Center. Started Feb 2013; status: recruiting.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON37380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37380.